Positive response of a primary malignant pericardial mesothelioma to pemetrexed plus cisplatin followed by pemetrexed maintenance chemotherapy: A case report

Sang Mi Chung, Seong Ji Choi, Min Jung Kim, Jung Yoon Choi, Hong Jun Kim, Suk Young Lee, Eun Joo Kang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Primary malignant pericardial mesothelioma (PMPM) is a rare tumor with poor prognosis. Surgery is the treatment of choice, but numerous cases are inoperable. For the treatment of inoperable or metastatic cases, systemic chemotherapy is required. However, a standard chemotherapeutic regimen for the treatment of pericardial mesothelioma has not yet been established. Chemotherapy involving pemetrexed and cisplatin has been actively used in the treatment of pleural or peritoneal mesothelioma, and may be considered for the treatment of PMPM. The present study reports the case of a patient with PMPM with lung metastasis who demonstrated a positive response to treatment with pemetrexed and cisplatin followed by pemetrexed maintenance chemotherapy, leading to prolonged progression-free survival for 21 months.

Original languageEnglish
Pages (from-to)213-216
Number of pages4
JournalOncology Letters
Volume12
Issue number1
DOIs
Publication statusPublished - 2016 Jul 1

Fingerprint

Pemetrexed
Maintenance Chemotherapy
Cisplatin
Mesothelioma
Therapeutics
Drug Therapy
Disease-Free Survival
Malignant Mesothelioma
Neoplasm Metastasis
Lung

Keywords

  • Chemotherapy
  • Cisplatin
  • Malignant mesothelioma
  • Pemetrexed
  • Pericardium

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Positive response of a primary malignant pericardial mesothelioma to pemetrexed plus cisplatin followed by pemetrexed maintenance chemotherapy : A case report. / Chung, Sang Mi; Choi, Seong Ji; Kim, Min Jung; Choi, Jung Yoon; Kim, Hong Jun; Lee, Suk Young; Kang, Eun Joo.

In: Oncology Letters, Vol. 12, No. 1, 01.07.2016, p. 213-216.

Research output: Contribution to journalArticle

Chung, Sang Mi ; Choi, Seong Ji ; Kim, Min Jung ; Choi, Jung Yoon ; Kim, Hong Jun ; Lee, Suk Young ; Kang, Eun Joo. / Positive response of a primary malignant pericardial mesothelioma to pemetrexed plus cisplatin followed by pemetrexed maintenance chemotherapy : A case report. In: Oncology Letters. 2016 ; Vol. 12, No. 1. pp. 213-216.
@article{e60933db0fb24ed68c1ea2ae4f010f95,
title = "Positive response of a primary malignant pericardial mesothelioma to pemetrexed plus cisplatin followed by pemetrexed maintenance chemotherapy: A case report",
abstract = "Primary malignant pericardial mesothelioma (PMPM) is a rare tumor with poor prognosis. Surgery is the treatment of choice, but numerous cases are inoperable. For the treatment of inoperable or metastatic cases, systemic chemotherapy is required. However, a standard chemotherapeutic regimen for the treatment of pericardial mesothelioma has not yet been established. Chemotherapy involving pemetrexed and cisplatin has been actively used in the treatment of pleural or peritoneal mesothelioma, and may be considered for the treatment of PMPM. The present study reports the case of a patient with PMPM with lung metastasis who demonstrated a positive response to treatment with pemetrexed and cisplatin followed by pemetrexed maintenance chemotherapy, leading to prolonged progression-free survival for 21 months.",
keywords = "Chemotherapy, Cisplatin, Malignant mesothelioma, Pemetrexed, Pericardium",
author = "Chung, {Sang Mi} and Choi, {Seong Ji} and Kim, {Min Jung} and Choi, {Jung Yoon} and Kim, {Hong Jun} and Lee, {Suk Young} and Kang, {Eun Joo}",
year = "2016",
month = "7",
day = "1",
doi = "10.3892/ol.2016.4598",
language = "English",
volume = "12",
pages = "213--216",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Positive response of a primary malignant pericardial mesothelioma to pemetrexed plus cisplatin followed by pemetrexed maintenance chemotherapy

T2 - A case report

AU - Chung, Sang Mi

AU - Choi, Seong Ji

AU - Kim, Min Jung

AU - Choi, Jung Yoon

AU - Kim, Hong Jun

AU - Lee, Suk Young

AU - Kang, Eun Joo

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Primary malignant pericardial mesothelioma (PMPM) is a rare tumor with poor prognosis. Surgery is the treatment of choice, but numerous cases are inoperable. For the treatment of inoperable or metastatic cases, systemic chemotherapy is required. However, a standard chemotherapeutic regimen for the treatment of pericardial mesothelioma has not yet been established. Chemotherapy involving pemetrexed and cisplatin has been actively used in the treatment of pleural or peritoneal mesothelioma, and may be considered for the treatment of PMPM. The present study reports the case of a patient with PMPM with lung metastasis who demonstrated a positive response to treatment with pemetrexed and cisplatin followed by pemetrexed maintenance chemotherapy, leading to prolonged progression-free survival for 21 months.

AB - Primary malignant pericardial mesothelioma (PMPM) is a rare tumor with poor prognosis. Surgery is the treatment of choice, but numerous cases are inoperable. For the treatment of inoperable or metastatic cases, systemic chemotherapy is required. However, a standard chemotherapeutic regimen for the treatment of pericardial mesothelioma has not yet been established. Chemotherapy involving pemetrexed and cisplatin has been actively used in the treatment of pleural or peritoneal mesothelioma, and may be considered for the treatment of PMPM. The present study reports the case of a patient with PMPM with lung metastasis who demonstrated a positive response to treatment with pemetrexed and cisplatin followed by pemetrexed maintenance chemotherapy, leading to prolonged progression-free survival for 21 months.

KW - Chemotherapy

KW - Cisplatin

KW - Malignant mesothelioma

KW - Pemetrexed

KW - Pericardium

UR - http://www.scopus.com/inward/record.url?scp=84973487281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973487281&partnerID=8YFLogxK

U2 - 10.3892/ol.2016.4598

DO - 10.3892/ol.2016.4598

M3 - Article

AN - SCOPUS:84973487281

VL - 12

SP - 213

EP - 216

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 1

ER -